Perspectivas del mercado y visión del analista:
La malaria es una enfermedad potencialmente mortal causada por el parásito Plasmodium. El mercado de diagnóstico de malaria está creciendo debido a la alta incidencia de malaria en países de bajos ingresos y a los programas de eliminación de malaria implementados a nivel mundial por organizaciones internacionales y nacionales. Los crecientes lanzamientos de herramientas de diagnóstico avanzadas y las crecientes actividades de investigación para terapias efectivas están contribuyendo aún más al crecimiento del mercado.
Antes de la pandemia de COVID-19, casi un tercio de las naciones endémicas estaban avanzando hacia objetivos internacionales. Muchas naciones con baja incidencia formaron parte de la "Iniciativa Eliminación 2025" de la OMS, que está representada por un grupo de 25 naciones que se esfuerzan por eliminar potencialmente la malaria para 2025. Por otro lado, el progreso se estancó en aproximadamente un tercio de los países. , mientras que en los demás países aumentó la incidencia de la malaria. Los países con mayor carga de morbilidad están mostrando una mayor inclinación a utilizar datos de pruebas de diagnóstico para estratificar y enfocar intervenciones geográficamente adecuadas, independientemente de la continua importancia de las pruebas y la detección en los intentos de erradicación.
Los casos y las muertes por malaria aumentaron en el primer año. de la epidemia de COVID-19 debido a interrupciones menores en el manejo de casos y los esfuerzos preventivos. No obstante, se evitó el peor de los casos posible (la duplicación de las muertes por malaria) gracias a los esfuerzos cooperativos de la OMS, los programas nacionales contra la malaria y sus socios. Dificultades para obtener los suministros necesarios contra la malaria y el patrón incierto de cómo la pandemia afectó en última instancia a las medidas de manejo de la malaria.
Impulsores del crecimiento:
La malaria, una de las enfermedades febriles agudas, es causada por parásitos plasmodium y se propaga a través de las hembras infectadas de Anopheles. mosquitos. Cinco especies de parásitos en humanos causan principalmente malaria, y dos de estas especies (Plasmodium falciparum y P. vivax) se consideran la mayor amenaza. Además, P. falciparum es el parásito de la malaria más mortífero y está más extendido en todo el continente africano. Además, P. vivax es el parásito de la malaria dominante en la mayoría de los países fuera del África subsahariana. Según el Informe Mundial sobre la Malaria (WMR) 2020 de la Organización Mundial de la Salud (OMS), se notificaron 241 millones de casos de malaria en todo el mundo, frente a los 227 millones de casos registrados en 2019. Según la misma fuente, aumenta el número de muertes causadas por la malaria en 69.000 al año. Aproximadamente dos tercios de estas muertes, es decir, 47.000, fueron causadas por interrupciones en los servicios de salud durante la pandemia de COVID-19; el tercio restante de las muertes, es decir, 22 000, reflejó un cambio reciente en la metodología de la OMS para calcular la mortalidad por malaria (independientemente de las interrupciones del COVID-19).
En 2020, ~95 % de los casos globales y ~96 % de las muertes causadas por la malaria se notificaron en la región africana de la OMS, y ~80% del total de muertes notificadas ocurrieron en niños de 5 años o menos. Según WMR 2021, aproximadamente el 2 % de la carga mundial de malaria se registró en los países del Sudeste Asiático, donde la India representó el 83 % de los casos estimados de malaria y el 82 % de las muertes asociadas con la enfermedad en 2020. Por lo tanto, la creciente prevalencia de la malaria en diferentes regiones a nivel mundial impulsa el crecimiento del mercado de diagnóstico de malaria.
Hay disponible en el mercado un número limitado de productos precalificados por la OMS que no son Pf mRDT. A pesar de la disponibilidad de una amplia gama de productos mRDT precalificados por la OMS, la demanda se concentra en torno a un subconjunto preferido de productos y fabricantes específicos. Esto limita la capacidad del mercado para garantizar la diversidad de la oferta, la seguridad y la capacidad de producción. En línea con esto, los fabricantes enfrentan desafíos como la baja demanda de productos por parte de algunos países, así como su desgana y falta de interés en adoptar productos alternativos. La adopción de marcas alternativas puede ser provocada por el cambio de marcas seleccionadas para los algoritmos nacionales o por implicaciones de costos.
Perspectivas estratégicas
Segmentación y alcance del informe:
El “mercado de diagnóstico de malaria” está segmentado según la tecnología y usuario final. El mercado de diagnóstico de malaria, por tecnología, se segmenta en microscopía, pruebas de diagnóstico rápido (PDR) y pruebas de diagnóstico molecular. El segmento de pruebas de diagnóstico rápido (RDT) tuvo la mayor participación de mercado en 2022 y se estima que registrará la CAGR más alta del mercado durante 2022-2030. El mercado de diagnóstico de malaria, por usuario final, se divide en hospitales y clínicas, centros de diagnóstico y otros. El segmento de hospitales y clínicas tuvo la mayor participación de mercado en 2022. Se espera que el segmento de centros de diagnóstico registre la CAGR más alta del mercado durante 2022-2030.
Análisis segmentario:
El mercado de diagnóstico de malaria, por tecnología, es segmentado en microscopía, pruebas de diagnóstico rápido (PDR) y pruebas de diagnóstico molecular.
Mercado de diagnóstico de malaria, por tecnología: 2022 y 2030
El segmento de pruebas de diagnóstico rápido (PDR) tuvo la mayor participación del mercado en 2022 y Se prevé que registre la CAGR más alta del mercado durante 2022-2030. Al demostrar la presencia de parásitos de la malaria en la sangre humana, las pruebas de diagnóstico rápido (PDR) de la malaria ayudan en el diagnóstico de la malaria. Las PDR ofrecen una alternativa al diagnóstico clínico o la microscopía, especialmente en situaciones en las que el acceso a servicios de microscopía de alta calidad es limitado. Plasmodium falciparum o P. vivax es la única especie que ciertas PDR pueden identificar, pero otras pueden identificar cuatro especies: P. falciparum, P. vivax, P. malariae y P. ovale. Por lo general, se utiliza un pinchazo en el dedo para extraer sangre para la prueba.
El mercado de diagnóstico de malaria, por usuario final, se segmenta en hospitales y clínicas, centros de diagnóstico y otros. Los hospitales y clínicas están evolucionando notablemente con el creciente número de pacientes en todo el mundo. Ofrecen tratamientos altamente efectivos en entornos de bajo costo. El creciente énfasis en el uso de PDR por sus rápidos tiempos de respuesta, bajos costos y fácil accesibilidad es una de las principales causas del predominio de las clínicas en el mercado de diagnóstico de malaria.
Análisis regional:
El diagnóstico global de malaria El mercado está segmentado geográficamente en América del Norte, Europa, Asia Pacífico, América del Sur y Central, y Medio Oriente y África. Debido a las crecientes inversiones por parte de países desarrollados como los EE. UU. y los EE. UU., el aumento de las poblaciones de pacientes y el creciente énfasis de la Organización Mundial de la Salud (OMS) en reducir la tasa de mortalidad por malaria en los países africanos, se prevé que la región de Medio Oriente y África mantener su dominio del mercado durante el período de pronóstico. Según los datos publicados por la OMS en julio de 2022, es probable que el África subsahariana represente aproximadamente el 95 % de los casos de enfermedades y el 96 % de las muertes.
Desarrollos de la industria y oportunidades futuras:
Varios desarrollos estratégicos por A continuación se enumeran los principales actores que operan en el mercado de diagnóstico de malaria:
En febrero de 2022, el Instituto de Investigación Médica de Kenia (KEMRI) lanzó Plasmochek para pruebas de malaria. Plasmochek está diseñado para detectar plasmodium, un parásito responsable de causar la malaria. El kit utiliza anticuerpos específicos de la proteína II rica en histidina de Plasmodium falciparum y la lactato deshidrogenasa de Plasmodium para detectar infecciones por malaria. En diciembre de 2019, Access Bio y Global Good (un socio colaborador del primero) desarrollaron una nueva prueba de diagnóstico rápido ultrasensible (uRDT ) que es cinco veces más sensible para identificar antígenos de la proteína 2 rica en histidina (HRP2) que los uRDT disponibles actualmente. Además, se ha creado una variedad de herramientas para mejorar el diagnóstico de malaria. Panorama competitivo y empresas clave:
Access Bio., Inc.; Laboratorios Abbott; Premier Medical Corporation Pvt. Limitado. Limitado.; Sysmex Partec GmbH; bioMérieux; Beckman Coulter Inc.; Siemens Healthineers; Leica Microsystems GmbH; Corporación Nikon; Corporación Olimpo; y Bio-Rad Laboratories Inc. son las empresas destacadas en el mercado de diagnóstico de malaria. Estas empresas se centran en nuevas tecnologías, actualización de productos existentes y expansiones geográficas para satisfacer la creciente demanda de los consumidores en todo el mundo.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors that are driving growth of the market are increasing research and development activities and advancements in informatic solutions and imaging systems.
Malaria is a life-threatening disease caused by the plasmodium parasite. The malaria diagnostics market is growing due to the high incidence of malaria in low-income countries and globally implemented malaria elimination programs by international and national organizations. The increasing launches of advanced diagnostic tools and rising research activities for effective therapeutics are further contributing to the growth of the market.
The malaria diagnostics market majorly consists of the players such as Access Bio., Inc.; Abbott Laboratories; Premier Medical Corporation Pvt. Ltd.; Sysmex Partec GmbH; bioMerieux; Beckman Coulter Inc.; Siemens Healthineers; Leica Microsystems GmbH; Nikon Corporation; Olympus Corporation; and Bio-Rad Laboratories Inc. among others.
The malaria diagnostics market, based on technology, is segmented into microscopy, rapid diagnostic tests (RDTs), and molecular diagnostic tests. The rapid diagnostic tests (RDTs) segment held the largest market share in 2022 and is estimated to register the highest CAGR in the market during 2022–2030.
Middle East and Africa holds the largest market share in malaria diagnostics market. Growing incidences of malaria is leading to increasing demand for malaria diagnostics. The market growth is owing to factors such as growing demand for rising awareness regarding malaria treatment and rising disposable income.
The malaria diagnostics market, based on end user, classified into hospitals and clinics, diagnostic centers, and others. The hospitals and clinics segment held the largest market share in 2022. The diagnostic centers segment is expected to register the highest CAGR in the market during 2022–2030.
Asia Pacific is expected to be the fastest growing region in the malaria diagnostics market. The growth of the market in Asia Pacific is anticipated to grow at a faster pace owing to factors such as growing need for superior treatment solutions, increasing focus on research and development activities. Additionally, India reported an 83.34% reduction in malaria morbidity and a 92% decrease in associated mortality during 2000–2019. The Centers for Disease Control and Prevention (CDC) claims that pregnant women are three times more susceptible to malaria infections as compared to others. Thus, rapid diagnosis and subsequent treatment plans are essential, which favor the growth of the malaria diadnostics market in India.
The List of Companies - Malaria Diagnostics Market
- Access Bio., Inc.
- Abbott Laboratories
- Premier Medical Corporation Pvt. Ltd.
- Sysmex Partec GmbH
- bioMérieux
- Beckman Coulter, Inc.
- Siemens Healthineers
- Leica Microsystems GmbH
- Nikon Corporation
- Olympus Corporation
- Bio-Rad Laboratories, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jan 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jan 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jan 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jan 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jan 2024
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)